# Interest of the Presepsin Assay as a Biomarker of Bacterial Infection, in the Management of Newborns and Infants Under 3 Months of Age Admitted for Fever in Pediatric Emergency Service (Presepsin)

> **NCT04076345** · — · TERMINATED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 31 (actual)

## Conditions studied

- Newborn Sepsis
- Fever

## Interventions

- **DIAGNOSTIC_TEST:** Prespesin assay on PATHFAST analyser

## Key facts

- **NCT ID:** NCT04076345
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-29
- **Primary completion:** 2020-07-29
- **Final completion:** 2020-07-29
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** investigator not available
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04076345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04076345, "Interest of the Presepsin Assay as a Biomarker of Bacterial Infection, in the Management of Newborns and Infants Under 3 Months of Age Admitted for Fever in Pediatric Emergency Service (Presepsin)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04076345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*